Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
2.695
+0.085 (3.26%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Relay Therapeutics Employees
Relay Therapeutics had 261 employees as of December 31, 2024. The number of employees decreased by 62 or -19.20% compared to the previous year.
Employees
261
Change (1Y)
-62
Growth (1Y)
-19.20%
Revenue / Employee
$38,341
Profits / Employee
-$1,293,900
Market Cap
456.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 261 | -62 | -19.20% |
| Dec 31, 2023 | 323 | -4 | -1.22% |
| Dec 31, 2022 | 327 | 82 | 33.47% |
| Dec 31, 2021 | 245 | 86 | 54.09% |
| Dec 31, 2020 | 159 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
RLAY News
- 6 days ago - Relay Therapeutics: Trying To Find That Right Price - Seeking Alpha
- 7 weeks ago - Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates - GlobeNewsWire
- 7 weeks ago - Relay Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025 - GlobeNewsWire
- 2 months ago - Relay Therapeutics: A Precision Oncology Play Worth The Risk - Seeking Alpha
- 3 months ago - Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival - GlobeNewsWire
- 4 months ago - Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium - GlobeNewsWire